The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.
The following is a summary of “Therapeutic outcomes and safety of radiofrequency ablation for primary papillary thyroid ...
In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...
A large-scale study of low-risk thyroid cancer patients proved that the quality of life can be maintained with 'active ...